The scientists found that HSV-1 activates transposable elements that impact the accumulation of Alzheimer's-linked proteins ...

The AGBT meeting has begun in Marco Island, Florida and Julianna LeMieux is on the ground. Here, she shares the latest news ...

Healx has dosed the first patient in a Phase II trial assessing its lead pipeline candidate HLX-1502 in patients with neurofibromatosis type 1 (NF1), while the FDA approved SpringWorks Therapeutics’ ...

AI tool uses MRI scans to track the pace of brain changes, mapping anatomic variations in regional brain aging rates according to factors including sex and age.

Roche introduces Sequencing by Expansion (SBX) technology in a webinar just a few days before the AGBT meeting takes place in ...

Researchers say understanding how Zika virus spreads through the human placenta and reaches the fetus is critical to prevent or control the infection.

Illumina announces a new NGS-based spatial technology kit and new software platform, Illumina Connected Multiomics.

Some of the funds will be used to develop multiomics solutions based on Atrandi's proprietary technology for single-cell ...

Like other developers of recently approved gene therapies, Bluebird has been slow to generate demand for its products. That reflects challenges in securing reimbursement from payers stemming from ...

Researchers say study provides sufficient rationale to further explore the therapeutic uses of SSRIs during infection.

The Mt. Sinai study could open the door to future therapies for Alzheimer’s, amyotrophic lateral sclerosis, brain cancer, and ...

The NIH projected the cut will save it $4 billion during the current federal fiscal year, which ends September 30. That’s ...